CIK 0001000694
- Large accelerated filer
NOVAVAX INC
Sign in to watch- Ticker
- NVAX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222816046
- Phone
- +1 240-268-2000
- Business address
- 21 FIRSTFIELD RD, GAITHERSBURG, MD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-28 | Herrmann John A III EVP, Chief Legal Officer | Sale | −719.55 | $113.02 | $81K | 21,180 |
| 2020-09-28 | Herrmann John A III EVP, Chief Legal Officer | Sale | −396.99 | $113.81 | $45K | 20,783 |
| 2020-09-28 | Herrmann John A III EVP, Chief Legal Officer | Sale | −992.48 | $115.23 | $114K | 19,791 |
| 2020-09-28 | Herrmann John A III EVP, Chief Legal Officer | Sale | −941.12 | $116.08 | $109K | 18,850 |
| 2020-09-28 | Herrmann John A III EVP, Chief Legal Officer | Sale | −545.86 | $117.07 | $64K | 18,304 |
| 2020-09-28 | Herrmann John A III EVP, Chief Legal Officer | Exercise or conversion · Stock Option (Right to Buy) | −24,750 | 74,250 | ||
| 2020-09-28 | Glenn Gregory M President, R&D | Exercise or conversion | +25,000 | $5.95 | $149K | 46,510 |
| 2020-09-28 | Glenn Gregory M President, R&D | Sale | −275.69 | $107.22 | $30K | 46,235 |
| 2020-09-28 | Glenn Gregory M President, R&D | Sale | −3,739.1 | $108.20 | $405K | 42,496 |
| 2020-09-28 | Glenn Gregory M President, R&D | Sale | −6,661.4 | $109.07 | $727K | 35,834 |
| 2020-09-28 | Glenn Gregory M President, R&D | Sale | −8,132.83 | $109.98 | $894K | 27,701 |
| 2020-09-28 | Glenn Gregory M President, R&D | Sale | −2,343.11 | $110.97 | $260K | 25,358 |
| 2020-09-28 | Glenn Gregory M President, R&D | Sale | −215.54 | $111.92 | $24K | 25,143 |
| 2020-09-28 | Glenn Gregory M President, R&D | Sale | −726.82 | $113.02 | $82K | 24,416 |
| 2020-09-28 | Glenn Gregory M President, R&D | Sale | −401 | $113.81 | $46K | 24,015 |
| 2020-09-28 | Glenn Gregory M President, R&D | Sale | −1,002.51 | $115.23 | $116K | 23,012 |
| 2020-09-28 | Glenn Gregory M President, R&D | Sale | −950.63 | $116.08 | $110K | 22,062 |
| 2020-09-28 | Glenn Gregory M President, R&D | Sale | −551.38 | $117.07 | $65K | 21,510 |
| 2020-09-28 | Glenn Gregory M President, R&D | Exercise or conversion · Stock Option (Right to Buy) | −25,000 | 75,000 | ||
| 2020-09-28 | Trizzino John EVP, CBO and CFO | Exercise or conversion | +25,000 | $5.95 | $149K | 48,408 |
Page 78 of 87 · 1,734 trades